Treatment of MCF-7 and MCF-7/ER(Y537S) cells with the anti-MUC1-C ADC was effective in inhibiting self-renewal capacity, indicating that these HR+/HER2− BC CSCs are MUC1-C-dependent. This evidence concerns the gene ERBB2 and breast cancer.